Michael Luebbert

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

Medicine, Hematology, Internal Medicine +12

Time-dependent changes in mortality and transformation risk in MDS

Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz et al. · Blood · 2016 · 175 citations · Full text

Public Health, Biostatistics, Survival Analysis +10

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Matteo Giovanni Della Porta, Heinz Tuechler, Luca Malcovati et al. · Leukemia · 2015 · 136 citations · Full text

Medicine, Clinical Sciences, Hematology +15

Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up

J. Thiele, H. M. Kvasnicka, G. Zerhusen et al. · Annals of Hematology · 2004 · 30 citations

Medicine, Hematology, Pathology +13

Decitabine Versus Hydroxyurea for Advanced Proliferative CMML: Results of the Emsco Randomized Phase 3 Dacota Trial

Raphaël Itzykson, Valeria Santini, Cendrine Chaffaut et al. · Blood · 2020 · 29 citations

Medicine, Oncology, Pharmacology +7